Optimizing Infectious Disease Payer Portal Automation

The Challenge of Manual Payer Portal Workflows in ID

The prior authorization process for infectious disease treatments, particularly high-cost antivirals (e.g., for HCV, HIV), antifungals, and OPAT, frequently encounters bottlenecks due to manual payer portal interactions. Revenue cycle teams face high time-per-PA, transcription errors when moving data from EMRs, and coordinator burnout from repetitive tasks. Each payer's unique portal interface, login requirements, and submission semantics add layers of complexity to an already critical workflow.

Specific Prior Authorization Triggers in Infectious Disease

Prior authorization is commonly triggered in Infectious Disease for high-cost medications and complex treatment plans. Key categories include antivirals for Hepatitis C (HCV) and HIV regimens, specific antifungals, and comprehensive plans for Outpatient Parenteral Antibiotic Therapy (OPAT). These PAs require detailed clinical documentation, including patient demographics, diagnosis codes, lab results, and treatment history, which must be accurately transferred to payer portals.

Klivira's Automated Payer Portal Workflow for ID

• **Headless Browser Automation:** Klivira operates automated, headless browser sessions against payer portals, performing login, navigation, form submission, and attachment uploads for ID-specific PAs.
• **Per-Payer Adapter Pattern:** Our platform maintains specific adapters for each payer portal, handling unique form fields, multi-step submission flows, and attachment requirements relevant to infectious disease treatments.
• **EMR Data Integration:** Patient demographics, clinical context, and necessary attachments are automatically extracted from your EMR system via FHIR-based integration, reducing manual data entry and transcription errors for ID PAs.
• **Automated Status Checking:** The system automatically polls payer portals for status updates on submitted prior authorizations for antivirals, antifungals, and OPAT, providing real-time visibility without manual intervention.
• **Resilience to Portal Changes:** Adapters are versioned and updated to accommodate payer portal modifications, ensuring continuous automation without disrupting active ID prior authorization workflows.

Bridging the Gap to API-Driven PA with CMS-0057-F

Klivira's payer portal automation serves as a critical transitional architecture, addressing the current landscape where many payers, particularly smaller commercial and regional Medicaid plans, lack robust API capabilities for prior authorization. While the CAQH Index indicates electronic PA adoption has historically lagged, the forthcoming CMS-0057-F mandate requires impacted payers to implement FHIR-based Prior Authorization APIs by January 2027. Klivira's platform is designed to route PA requests preferentially through API channels (e.g., Da Vinci PAS, X12 278) when available, gracefully falling back to portal automation otherwise, ensuring a smooth migration trajectory.

Operational Benefits for Infectious Disease Practices

• **Reduced Time-per-PA:** Significantly decreases the administrative time spent on prior authorizations for high-cost ID medications by automating repetitive portal tasks.
• **Minimized Transcription Errors:** Ensures accurate data flow from your EMR to payer portals, eliminating manual data entry mistakes that can delay approvals for antivirals or OPAT.
• **Improved Coordinator Efficiency:** Frees up prior authorization coordinators from manual, repetitive work, allowing them to focus on complex cases and clinical appeals.
• **Faster Patient Access:** Accelerates the approval process for critical infectious disease treatments, ensuring patients receive timely access to necessary therapies.
• **Enhanced Visibility:** Provides a centralized view of all prior authorization statuses, including those submitted via payer portals, improving workflow transparency.